| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aligos Therapeutics Inc (NASDAQ: ALGS)
ALGS Technical Analysis
5
| As on 9th Jun 2023 ALGS STOCK Price closed @ 1.12 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.29 & Strong Sell for SHORT-TERM with Stoploss of 5.18 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALGSSTOCK Price
| Open | 1.12 | Change | Price | % |
| High | 1.16 | 1 Day | 0.02 | 1.82 |
| Low | 1.09 | 1 Week | 0.00 | 0.00 |
| Close | 1.12 | 1 Month | 0.09 | 8.74 |
| Volume | 35246 | 1 Year | -10.90 | -90.68 |
| 52 Week High 12.36 | 52 Week Low 0.87 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ALGS Daily Charts |
ALGS Intraday Charts |
Whats New @ Bazaartrend |
ALGS Free Analysis |
|
|
ALGS Important Levels Intraday
| RESISTANCE | 1.25 |
| RESISTANCE | 1.21 |
| RESISTANCE | 1.18 |
| RESISTANCE | 1.16 |
| SUPPORT | 1.08 |
| SUPPORT | 1.06 |
| SUPPORT | 1.03 |
| SUPPORT | 0.99 |
ALGS Forecast May 2024
| 4th UP Forecast | 19.14 |
| 3rd UP Forecast | 13.36 |
| 2nd UP Forecast | 9.79 |
| 1st UP Forecast | 6.22 |
| 1st DOWN Forecast | -3.98 |
| 2nd DOWN Forecast | -7.55 |
| 3rd DOWN Forecast | -11.12 |
| 4th DOWN Forecast | -16.9 |
ALGS Weekly Forecast
| 4th UP Forecast | 3.97 |
| 3rd UP Forecast | 3.06 |
| 2nd UP Forecast | 2.49 |
| 1st UP Forecast | 1.93 |
| 1st DOWN Forecast | 0.31 |
| 2nd DOWN Forecast | -0.25 |
| 3rd DOWN Forecast | -0.82 |
| 4th DOWN Forecast | -1.73 |
ALGS Forecast2024
| 4th UP Forecast | 24.05 |
| 3rd UP Forecast | 16.7 |
| 2nd UP Forecast | 12.15 |
| 1st UP Forecast | 7.61 |
| 1st DOWN Forecast | -5.37 |
| 2nd DOWN Forecast | -9.91 |
| 3rd DOWN Forecast | -14.46 |
| 4th DOWN Forecast | -21.81 |
Aligos Therapeutics Inc ( NASDAQ USA Symbol : ALGS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALGS Business Profile
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a synthetic oligonucleotide that is in Phase I clinical trial for the treatment of chronic hepatitis B (CHB); and ALG-000184, a capsid assembly modulator, which is in Phase I clinical trials to treat CHB. The company is also developing ALG-020572, an antisense oligonucleotide to decrease HBsAg levels; and ALG-055009, a small molecule THR-ß agonist for the treatment of non-alcoholic steatohepatitis. In addition, it is developing siRNA drug candidate, ALG-125755, as well as ALG-125097 and ALG-125819, demonstrated potent inhibition of HBsAg release from HBV-infected cells. The company has entered into license and collaboration agreements with Luxna Biotech Co., Ltd. to develop and commercialize products containing oligonucleotides targeting SARS-CoV-2; and research, licensing, and commercialization agreement with Katholieke Universiteit Leuven to develop coronavirus protease inhibitors. Aligos Therapeutics, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California. Address: One Corporate Drive, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service